Deciphera Pharmaceuticals, based in Waltham, Mass., announced it is restructuring with the intention of prioritizing clinical development of specific programs and streamlining its commercial operations. In addition to cutting one of its programs, it plans to reduce about 35% of its staff, or about 140 positions. The company believes these actions can extend their cash runway into 2024.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,